IQV · News · 20260805N

Products and Technology

IQVIA HOLDINGS INC. · 2026-08-05 · Importance 31 · Surprise 42

IQVIA and Medera announced a strategic collaboration to accelerate cardiac gene-therapy development and human-based drug discovery. IQVIA will contribute its clinical-trial infrastructure and Medera will contribute its work in gene therapy. The collaboration expands IQVIA’s participation in innovative drug development and cardiac therapeutics.

Key facts

• A Simply Wall St. article states IQVIA's new alliance with Medera leverages IQVIA's clinical trial infrastructure and Medera's gene therapy work to advance cardiac gene therapy and human-based drug discovery. source
• The Simply Wall St. piece links the Medera alliance to IQVIA's existing focus on AI-powered data platforms and R&D solutions. source